Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 57

1.

Carnosic acid prevents obesity and hepatic steatosis in ob/ob mice.

Wang T, Takikawa Y, Satoh T, Yoshioka Y, Kosaka K, Tatemichi Y, Suzuki K.

Hepatol Res. 2011 Jan;41(1):87-92. doi: 10.1111/j.1872-034X.2010.00747.x.

PMID:
21199201
2.

Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.

Malloy VL, Perrone CE, Mattocks DA, Ables GP, Caliendo NS, Orentreich DS, Orentreich N.

Metabolism. 2013 Nov;62(11):1651-61. doi: 10.1016/j.metabol.2013.06.012. Epub 2013 Aug 5.

PMID:
23928105
3.

Beta-aminoisobutyric acid prevents diet-induced obesity in mice with partial leptin deficiency.

Begriche K, Massart J, Abbey-Toby A, Igoudjil A, Lettéron P, Fromenty B.

Obesity (Silver Spring). 2008 Sep;16(9):2053-67. doi: 10.1038/oby.2008.337.

4.

Effects of bile acid sequestration on hepatic steatosis in obese mice.

Solís N, Pizarro M, Quintero P, Arab JP, Riquelme A, Padilla O, Carrasco G, Pirola CJ, Sookoian S, Arrese M.

Ann Hepatol. 2013 Jan-2014 Feb;13(1):105-12.

5.

Anti-obesity effects of KR-66195, a synthetic DPP-IV inhibitor, in diet-induced obese mice and obese-diabetic ob/ob mice.

Lee EY, Kim YW, Oh H, Choi CS, Ahn JH, Lee BW, Kang ES, Cha BS, Lee HC.

Metabolism. 2014 Jun;63(6):793-9. doi: 10.1016/j.metabol.2014.02.011. Epub 2014 Feb 25.

PMID:
24684824
6.
7.

Amelioration of non-alcoholic steatohepatitis and glucose intolerance in ob/ob mice by oral immune regulation towards liver-extracted proteins is associated with elevated intrahepatic NKT lymphocytes and serum IL-10 levels.

Elinav E, Pappo O, Sklair-Levy M, Margalit M, Shibolet O, Gomori M, Alper R, Thalenfeld B, Engelhardt D, Rabbani E, Ilan Y.

J Pathol. 2006 Jan;208(1):74-81.

PMID:
16261527
8.

Triphala and its constituents ameliorate visceral adiposity from a high-fat diet in mice with diet-induced obesity.

Gurjar S, Pal A, Kapur S.

Altern Ther Health Med. 2012 Nov-Dec;18(6):38-45.

PMID:
23251942
9.

A novel aminosterol reverses diabetes and fatty liver disease in obese mice.

Takahashi N, Qi Y, Patel HR, Ahima RS.

J Hepatol. 2004 Sep;41(3):391-8.

PMID:
15336441
10.

Carnosic acid (CA) prevents lipid accumulation in hepatocytes through the EGFR/MAPK pathway.

Wang T, Takikawa Y, Tabuchi T, Satoh T, Kosaka K, Suzuki K.

J Gastroenterol. 2012 Jul;47(7):805-13. doi: 10.1007/s00535-012-0546-7. Epub 2012 Feb 18.

PMID:
22350699
11.

PYY transgenic mice are protected against diet-induced and genetic obesity.

Boey D, Lin S, Enriquez RF, Lee NJ, Slack K, Couzens M, Baldock PA, Herzog H, Sainsbury A.

Neuropeptides. 2008 Feb;42(1):19-30. doi: 10.1016/j.npep.2007.11.003. Epub 2007 Dec 27.

PMID:
18164057
12.
13.

Partial leptin deficiency favors diet-induced obesity and related metabolic disorders in mice.

Begriche K, Lettéron P, Abbey-Toby A, Vadrot N, Robin MA, Bado A, Pessayre D, Fromenty B.

Am J Physiol Endocrinol Metab. 2008 May;294(5):E939-51. doi: 10.1152/ajpendo.00379.2007. Epub 2008 Mar 18.

14.

Ezetimibe decreases SREBP-1c expression in liver and reverses hepatic insulin resistance in mice fed a high-fat diet.

Muraoka T, Aoki K, Iwasaki T, Shinoda K, Nakamura A, Aburatani H, Mori S, Tokuyama K, Kubota N, Kadowaki T, Terauchi Y.

Metabolism. 2011 May;60(5):617-28. doi: 10.1016/j.metabol.2010.06.008. Epub 2010 Aug 2.

PMID:
20673929
15.

Enhancing liver mitochondrial fatty acid oxidation capacity in obese mice improves insulin sensitivity independently of hepatic steatosis.

Monsénégo J, Mansouri A, Akkaoui M, Lenoir V, Esnous C, Fauveau V, Tavernier V, Girard J, Prip-Buus C.

J Hepatol. 2012 Mar;56(3):632-9. doi: 10.1016/j.jhep.2011.10.008. Epub 2011 Oct 25.

PMID:
22037024
16.

Differential effects of low-dose resveratrol on adiposity and hepatic steatosis in diet-induced obese mice.

Cho SJ, Jung UJ, Choi MS.

Br J Nutr. 2012 Dec 28;108(12):2166-75. doi: 10.1017/S0007114512000347. Epub 2012 Mar 14.

PMID:
22414733
17.

Repetitive orogastric gavage affects the phenotype of diet-induced obese mice.

de Meijer VE, Le HD, Meisel JA, Puder M.

Physiol Behav. 2010 Jun 16;100(4):387-93. doi: 10.1016/j.physbeh.2010.04.001. Epub 2010 Apr 10.

18.

Dietary docosahexaenoic acid-rich diacylglycerols ameliorate hepatic steatosis and alter hepatic gene expressions in C57BL/6J-Lep(ob/ob) mice.

Kim HJ, Lee KT, Park YB, Jeon SM, Choi MS.

Mol Nutr Food Res. 2008 Aug;52(8):965-73. doi: 10.1002/mnfr.200700315.

PMID:
18481331
19.

Polyunsaturated fatty acids ameliorate hepatic steatosis in obese mice by SREBP-1 suppression.

Sekiya M, Yahagi N, Matsuzaka T, Najima Y, Nakakuki M, Nagai R, Ishibashi S, Osuga J, Yamada N, Shimano H.

Hepatology. 2003 Dec;38(6):1529-39.

PMID:
14647064
20.

Supplemental Content

Support Center